Umoja Biopharma, Inc. reported raising $210 Million in an initial SEC Form D filing, from an offering of $210 Million
Amount Raised
$210 Million
Round Type
Venture
SeattleBiotechnologyTherapeuticsQuick answer
Umoja Biopharma raised $210 Million in a funding round, dated June 24, 2021. Umoja Biopharma is based in Seattle, Washington, United States.
- How much did Umoja Biopharma raise?
- Umoja Biopharma raised $210 Million in a funding round on June 24, 2021.
- What does Umoja Biopharma do?
- Umoja Biopharma, Inc. is a clinical-stage biotechnology company aiming to develop off-the-shelf therapeutics that improve the reach, effectiveness, and access of CAR T cell therapies in both oncology and autoimmunity.
- Where is Umoja Biopharma based and how big is it?
- Umoja Biopharma is based in Seattle, Washington, United States. Fundz records about 191 employees.
- Who are the decision-makers at Umoja Biopharma?
- Fundz holds 1 contact at Umoja Biopharma. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Umoja Biopharma that raised within 45 days of this round, from Fundz verified event records.
- Renovacor, Inc. raised $2.5M (Seed) on August 4, 2021.
- Turnstone Biologics Corp raised $80M (Series D) on July 21, 2021.
- Amylyx Pharmaceuticals raised $135M (Series C) on July 20, 2021.
- Century Therapeutics raised $11M on July 19, 2021.
- Turnstone Biologics Corp raised $80M on July 14, 2021.
- Nimbus Therapeutics raised $105M (Funding Round) on July 13, 2021.
Who to call at Umoja Biopharma, and when
A new round usually means Umoja Biopharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Umoja Biopharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Umoja Biopharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Umoja Biopharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Umoja Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Umoja Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.